Guardian Science Weekly

‘The undruggable became druggable’: a breakthrough cancer treatment

Loading player...
A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial that experts are saying is a gamechanger and one of the biggest breakthroughs in decades. To find out more about how daraxonrasib works and how life-changing it could be for patients, Madeleine Finlay speaks to Prof Naureen Starling, consultant medical oncologist at the Royal Marsden hospital. Help support our independent journalism at theguardian.com/sciencepod
11 Jun English United Kingdom Science · Nature

Other recent episodes

We’re reading less. And it’s making us stupid

Books have never been trendier, but studies show that as more and more things compete for our frazzled attention spans, we’re reading less and less. This is a problem because reading has a wealth of cognitive benefits that we’re in danger of missing out on. To find out why declining…
11 Aug 19 min

The Wildlife Trusts’ fight to save a historic English landscape

Madeleine Finlay travels to the Rothbury estate in Northumberland, in north-east England. It’s a piece of land that has been in the same family for 700 years, but now it has been put up for sale and the UK’s Wildlife Trusts are trying to raise £30m to secure it intact…
4 Aug 16 min

Revisited: Saunas and cold plunges, where does the evidence stand?

Saunas and cold plunge pools are popping up everywhere in the UK, bringing fiery heat and icy cold to a beach, city farm or park near you. Their users will be ready with all the reasons why it’s good for both the mind and the body. But what’s the evidence…
30 Jul 16 min

Revisited: The surprising science of dreams and nightmares

In this episode from January 2026, Ian Sample puts listeners’ questions about dreams and nightmares to Dr Michelle Carr, the director of the Dream Engineering Laboratory in Montreal’s Centre for Advanced Research in Sleep Medicine, and the author of the book Into the Dream Lab. They look at why we…
28 Jul 22 min
All episodes